Dronapushpi (Leucas cephalotes Roth) arka nebulization in the management of Tamaka Shwasa (Bronchial asthma)

A Clinical Study to Evaluate the Shwasahara Karma of Dronapushpi (Leucas cephalotes Roth) Arka Nebulization in the Management of Tamaka Shwasa (Bronchial asthma)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/11/022081

Enrollment

Registered

2019-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma Health Condition 2: J452- Mild intermittent asthma

Interventions

Intervention1: A clinical study to evaluate the Shwasahara karma of Dronapushpi (Leucas cephalotes Roth) Arka Nebulization in the management of Tamaka Shwasa (Bronchial asthma): single dose of 8ml of

Eligibility

Inclusion criteria

Inclusion criteria: Conscious and well oriented Age 18-60yrs Either gender Previously diagnosed case of bronchial asthma

Exclusion criteria

Exclusion criteria: Subjects with a history of tuberculosis, emphysema, chronic airway limitation History of cardiac involvement Other complicated respiratory diseases having any organic lesions such as tumor or any anatomical defect in the airway. Cyanosis Hypertension

Design outcomes

Primary

Measure	Time frame
To assess the effect of Dronapushpi Arka Nebulisation in the management of Tamaka Shwasa(Bronchial asthma)Timepoint: Assessment will be done on Borderline and for every 15 minutes for 1 hour	—

Secondary

Measure	Time frame
Quality of LifeTimepoint: Assessment will be done on Borderline and for Every 15 Minutes for 1 Hour	—

Countries

India

Contacts

Public ContactDr Medha B Bhat

Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital Hassan

harini013@yahoo.co.in9886427831

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026